Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2822 Outcome of Systemic Therapy in Secondary High-Grade Pancreatic Neuroendocrine Tumors
Introduction: Platinum-based chemotherapy has been the recommended treatment for metastatic high-grade pancreatic neuroendocrine neoplasms (panNEN). This strategy has been questioned for pancreatic neuroendocrine tumor grade 3 (panNET G3). The most optimal treatment strategy for low/intermediate grade panNETs that show progression to a high grade (secondary panNET G3) is unknown.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Mollazadegan K, Botling J, Welin S, Eriksson B, Skogseid B,
Keywords: pancreas, neuroendocrine tumor, treatment,
Introduction: Telotristat ethyl (TE) is a treatment for carcinoid syndrome (CS) diarrhea used in combination with somatostatin analog (SSA) therapy. In the Phase 3, randomized, placebo-controlled, double-blind TELESTAR and TELECAST studies, CS patients received TE at 250 mg 3 times per day (tid), 500 mg tid, or placebo tid in addition to SSAs.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Dillon J, Kulke M, Warner R, Bergsland E, Welin S,
Keywords: telotristat ethyl, somatostatin analogs, carcinoid syndrome,
Introduction: Predicting treatment response at an early stage in the treatment algorithm for NET is highly desirable.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Kjellman M
Authors: Kjellman M, Knigge u, Welin S, Grønbæk H, Thiis-Evensen E,
Keywords: Plasma Protein Biomarker,
Introduction: siNETs are notoriously difficult to diagnose, especially in an early stage.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Kjellman M
Authors: Kjellman M, Knigge U, Welin S, Grønbæk H, This-Evensen E,
Keywords: NET biomarker diagnosis,
#906 Secondary Hormonal Syndromes in Patients with Sporadic Neuroendocrine Tumors
Introduction: Neuroendocrine tumors (NETs) are characterized by secretion of peptide hormones that may cause distinct syndromes. Although most patients with hormonal secretion are diagnosed upon primary diagnosis, a significant proportion of pancreatic NET patients develop secondary hormonal production later on in the disease.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Crona J, Eriksson B, Welin S,
Keywords: neuroendocrine tumor, prognostic factors,